JP2020530765A5 - - Google Patents
Info
- Publication number
- JP2020530765A5 JP2020530765A5 JP2020502118A JP2020502118A JP2020530765A5 JP 2020530765 A5 JP2020530765 A5 JP 2020530765A5 JP 2020502118 A JP2020502118 A JP 2020502118A JP 2020502118 A JP2020502118 A JP 2020502118A JP 2020530765 A5 JP2020530765 A5 JP 2020530765A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- seq
- composition
- self
- nucleic acid
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762533312P | 2017-07-17 | 2017-07-17 | |
| US62/533,312 | 2017-07-17 | ||
| PCT/IB2018/055258 WO2019016680A1 (en) | 2017-07-17 | 2018-07-16 | ANTIGEN CONSTRUCTS OF LYSSAVIRUS |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020530765A JP2020530765A (ja) | 2020-10-29 |
| JPWO2019016680A5 JPWO2019016680A5 (https=) | 2022-05-25 |
| JP2020530765A5 true JP2020530765A5 (https=) | 2022-05-25 |
Family
ID=63364109
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020502118A Pending JP2020530765A (ja) | 2017-07-17 | 2018-07-16 | リサウイルス抗原構築物 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US11278613B2 (https=) |
| EP (1) | EP3655536A1 (https=) |
| JP (1) | JP2020530765A (https=) |
| CN (1) | CN111108203A (https=) |
| BR (1) | BR112020000802A2 (https=) |
| CA (1) | CA3070042A1 (https=) |
| WO (1) | WO2019016680A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110269933A (zh) * | 2019-07-17 | 2019-09-24 | 苏州世诺生物技术有限公司 | 一种狂犬病毒亚单位疫苗的制备方法及其应用 |
| CN110643632B (zh) * | 2019-09-26 | 2022-06-10 | 中国科学院武汉病毒研究所 | 一种基于甲病毒复制子载体的狂犬病毒感染性克隆及制备方法和应用 |
| WO2022077330A1 (zh) * | 2020-10-15 | 2022-04-21 | 中国科学院深圳先进技术研究院 | 一种新型g基因及其在高效逆向跨单突触中的应用 |
| WO2022152939A1 (en) | 2021-01-18 | 2022-07-21 | Conserv Bioscience Limited | Coronavirus immunogenic compositions, methods and uses thereof |
| CN113993839B (zh) * | 2021-02-05 | 2024-02-09 | 嘉晨西海(杭州)生物技术有限公司 | 一种可离子化脂质分子、其制备方法及其在制备脂质纳米颗粒中的应用 |
| EP4342993A4 (en) * | 2021-05-19 | 2025-05-28 | Daiichi Sankyo Company, Limited | Hpv infectious disease vaccine |
| WO2023031858A1 (en) | 2021-09-01 | 2023-03-09 | Glaxosmithkline Biologicals Sa | Plasmid dna purification methods |
| WO2023151570A1 (en) * | 2022-02-09 | 2023-08-17 | Suzhou Abogen Biosciences Co., Ltd. | Nucleic acid vaccines for rabies |
| CN116120198B (zh) * | 2022-03-21 | 2024-03-15 | 苏州科锐迈德生物医药科技有限公司 | 具有甘油骨架的脂质化合物及基于其的脂质载体、核酸脂质纳米粒组合物和药物制剂 |
| CN116063410B (zh) * | 2022-10-20 | 2023-07-14 | 北京标驰泽惠生物科技有限公司 | 一种狂犬病毒g蛋白的突变体及其应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4368202A3 (en) | 2007-03-30 | 2024-08-21 | The Research Foundation for The State University of New York | Attenuated viruses useful for vaccines |
| BR112016001192A2 (pt) * | 2013-08-21 | 2017-08-29 | Curevac Ag | Vacina contra a raiva |
| EP4019506A1 (en) | 2013-12-19 | 2022-06-29 | Novartis AG | Lipids and lipid compositions for the delivery of active agents |
| ES2895651T3 (es) | 2013-12-19 | 2022-02-22 | Novartis Ag | Lípidos y composiciones lipídicas para la administración de agentes activos |
| US10125092B2 (en) | 2014-09-05 | 2018-11-13 | Novartis Ag | Lipids and lipid compositions for the delivery of active agents |
| CA3045976A1 (en) * | 2016-12-09 | 2018-06-14 | Glaxosmithkline Biologicals Sa | Chimpanzee adenovirus constructs with lyssavirus antigens |
| GB201620968D0 (en) | 2016-12-09 | 2017-01-25 | Glaxosmithkline Biologicals Sa | Adenovirus polynucleotides and polypeptides |
-
2018
- 2018-07-16 WO PCT/IB2018/055258 patent/WO2019016680A1/en not_active Ceased
- 2018-07-16 BR BR112020000802-8A patent/BR112020000802A2/pt not_active Application Discontinuation
- 2018-07-16 US US16/630,951 patent/US11278613B2/en not_active Expired - Fee Related
- 2018-07-16 CA CA3070042A patent/CA3070042A1/en active Pending
- 2018-07-16 JP JP2020502118A patent/JP2020530765A/ja active Pending
- 2018-07-16 CN CN201880060285.4A patent/CN111108203A/zh active Pending
- 2018-07-16 EP EP18759392.6A patent/EP3655536A1/en not_active Withdrawn
-
2022
- 2022-02-02 US US17/591,421 patent/US20220241398A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020530765A5 (https=) | ||
| US11998597B2 (en) | Vaccine against RSV | |
| JP7523897B2 (ja) | 呼吸器合胞体ウイルス（ｒｓｖ）ワクチン | |
| US20200069794A1 (en) | Respiratory virus nucleic acid vaccines | |
| AU2021380033A1 (en) | Compositions and methods for stabilization of lipid nanoparticle mrna vaccines | |
| EP4226938A2 (en) | Coronavirus vaccine | |
| CN111526886A (zh) | 多基因流感疫苗 | |
| JPWO2021213924A5 (https=) | ||
| JP2024537250A (ja) | インフルエンザワクチン | |
| WO2023051701A1 (zh) | 抗SARS-CoV-2感染的mRNA、蛋白以及抗SARS-CoV-2感染的疫苗 | |
| JP2025084850A (ja) | ハンタウイルス抗原性組成物 | |
| JPWO2019016680A5 (https=) | ||
| CN109923125B (zh) | 免疫原性组合物 | |
| CN120813371A (zh) | 用于在衣原体病的治疗中使用的组合物 | |
| JP2025516330A (ja) | 核酸ワクチンのシグナル配列 | |
| CN116650633A (zh) | 冠状病毒疫苗 | |
| WO2025251934A1 (zh) | 一种抗肝癌hla-a11型疫苗及其制备方法和应用 | |
| JP2026500282A (ja) | インフルエンザウイルス様粒子をコードするｍＲＮＡ | |
| JP2023155245A5 (https=) | ||
| EP3035960B1 (en) | Respiratory syncytial virus (rsv) vaccine | |
| US20250041400A1 (en) | Rsv vaccine | |
| HK40097472A (zh) | 冠状病毒疫苗 | |
| WO2025251935A1 (zh) | 一种抗肝癌hla-a02型疫苗及其制备方法和应用 | |
| WO2025260633A1 (zh) | Rsv和hmpv融合f蛋白及其用途 | |
| AU2023378779A1 (en) | Stabilized vaccines |